Literature DB >> 7885545

Estrogen receptor gene expression in craniopharyngiomas: an in situ hybridization study.

K Thapar1, L Stefaneanu, K Kovacs, B W Scheithauer, R V Lloyd, P J Muller, E R Laws.   

Abstract

Craniopharyngiomas are histologically benign epithelial neoplasms of the sellar region that frequently exhibit invasive and aggressive local growth. In this study, we have investigated the presence and cellular distribution of estrogen receptor messenger ribonucleic acid by in situ hybridization in 23 surgically removed craniopharyngiomas. All craniopharyngiomas studied, including 19 adamantinomatous and 4 papillary variants, uniformly expressed the estrogen receptor gene. In all cases, an intense estrogen receptor messenger ribonucleic acid hybridization signal was demonstrated; one localized exclusively to the epithelial cells of the tumor. Connective tissue and vascular elements were devoid of hybridization signal. Coexpression of the estrogen receptor protein was also studied by immunohistochemistry. Despite the relative abundance of estrogen receptor message in all cases studied, the estrogen receptor protein was focally but conclusively detected in only two tumors. The basis of this discrepancy is unclear. Progesterone receptor protein was also studied in all cases; however, its definitive presence was noted in only one instance and, in that case, in only occasional nuclei. The expression of the estrogen receptor gene by the proliferative epithelial elements of craniopharyngiomas raises the questions of a possible hormonal component to the genesis and/or progression of the craniopharyngiomas and a potential responsiveness to therapeutic hormonal manipulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7885545     DOI: 10.1227/00006123-199412000-00002

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  5 in total

1.  Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.

Authors:  L Jin; X Qian; E Kulig; N Sanno; B W Scheithauer; K Kovacs; W F Young; R V Lloyd
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Craniopharyngioma: a clinicopathological study of 141 cases.

Authors:  Seyed Mohammad Tavangar; Bagher Larijani; Ali Mahta; Seyed Mehdi Abdolahzadeh Hosseini; Masoud Mehrazine; Fatemeh Bandarian
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

3.  Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.

Authors:  K Thapar; K Kovacs; L Stefaneanu; B Scheithauer; D W Killinger; R V Lioyd; H S Smyth; A Barr; M O Thorner; B Gaylinn; E R Laws
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

4.  Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics.

Authors:  Antonio Martínez-Ortega; Álvaro Flores-Martinez; Eva Venegas-Moreno; Elena Dios; Diego Del Can; Eloy Rivas; Ariel Kaen; Eugenio Cárdenas Ruiz-Valdepeñas; Elena Fajardo; Florinda Roldán; Natividad González-Rivera; Rosario Oliva; José Ignacio Fernández-Peña; Alfonso Soto-Moreno; David A Cano
Journal:  J Clin Med       Date:  2022-01-05       Impact factor: 4.241

5.  Volume increase in craniopharyngiomas under growth hormone and/or sex hormones substitution: Role of tumors receptors or mere coincidence?

Authors:  F Chentli; S Deghima; H Zellagui; S Azzoug
Journal:  J Pediatr Neurosci       Date:  2013-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.